title: Ventricular arrhythmias and sudden death in patients taking ibrutinib.
authors.affiliation: Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Benjamin L
authors.identifier: 0000-0002-6033-3363
authors.initials: BL
authors.lastname: Lampson
authors.affiliation: Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Lijian
authors.initials: L
authors.lastname: Yu
authors.affiliation: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Glynn
authors.affiliation: Hofstra Northwell School of Medicine, Hempstead, NY.
authors.forename: Jacqueline C
authors.identifier: 0000-0001-6018-5535
authors.initials: JC
authors.lastname: Barrientos
authors.affiliation: Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Eric D
authors.initials: ED
authors.lastname: Jacobsen
authors.affiliation: Cancer Care Manitoba, Winnipeg, MB, Canada.
authors.forename: Versha
authors.identifier: 0000-0002-7415-8818
authors.initials: V
authors.lastname: Banerji
authors.affiliation: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Jones
authors.affiliation: Department of Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
authors.forename: Renata
authors.initials: R
authors.lastname: Walewska
authors.affiliation: Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
authors.forename: Kerry J
authors.identifier: 0000-0002-5835-9863
authors.initials: KJ
authors.lastname: Savage
authors.affiliation: Cardiovascular Division, Brigham and Women's Hospital, Boston, MA; and.
authors.forename: Gregory F
authors.initials: GF
authors.lastname: Michaud
authors.affiliation: Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
authors.forename: Javid J
authors.initials: JJ
authors.lastname: Moslehi
authors.affiliation: Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Brown
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D016757:Death, Sudden, Cardiac; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine